BP

Bhimsen Pareek

Active Director Director DIN 08326398
DIN 08326398 First appointment Jan 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value •••• Premium profile

About Bhimsen Pareek

Data last updated:

Bhimsen Pareek is a Director at Bitcan Pharma Private Limited (since 2019). The company operates in Trading. Bitcan Pharma Private Limited reported revenue of ₹31.8 Lakh (FY 2025).

DIN 08326398
Primary Designation Director
Industry Trading
First Appointment 09 Jan 2019
Oldest Company Age 7 yrs
Largest company Bitcan Pharma Private Limited · ₹31.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bitcan Pharma Private Limited U51909RJ2019PTC063567
Director09 Jan 20192019₹31.8 Lakh (FY 2025)Active

Board colleagues of Bhimsen Pareek

Directorship timeline

Open interactive timeline →
Bitcan Pharma Private Limited
Premium access

Shareholding and investment profile for Bhimsen Pareek

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhimsen Pareek

Bhimsen Pareek currently holds 1 directorship: Bitcan Pharma Private Limited (Director, since 09 Jan 2019, revenue ₹31.8 Lakh (FY 2025)).

Bhimsen Pareek was first appointed on 09 Jan 2019 as Director at Bitcan Pharma Private Limited.

The current boards of Bhimsen Pareek's companies include Abhay Kumar Yadav (Bitcan Pharma Private Limited), Mannan Ahamad Malkan (Bitcan Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available